China Daily The Chinese institute has also formed strong partnerships with the local scientific community on innovative research and drug discovery. So far, the center has been working closely with more than 40 academic and biotech partners in China in such areas ...
Financial Times Mr Read said he was more focused on generating more “visibility” around its two distinctive core prescription medicine businesses – the “value” division of existing off patent branded drugs and the core innovative “growth” unit of experimental drugs in ...
Bloomberg Cellmid Ltd., a Sydney-based drugmaker, also plans to start selling in China this year a plant extract -based treatment to which it acquired the rights through its purchase of Advangen Inc. Japan last ... 更多 »
